Gene: CLBA1
Official Full Name: clathrin binding box of aftiphilin containing 1provided by HGNC
Gene Summary: Predicted to enable clathrin binding activity. Predicted to be involved in intracellular transport. Predicted to be part of AP-1 adaptor complex. Predicted to be active in trans-Golgi network membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28909 | CLBA1 Knockout cell line (HeLa) | Human | CLBA1 | 1:3~1:6 | Negative | Online Inquiry |
KO28910 | CLBA1 Knockout cell line (HCT 116) | Human | CLBA1 | 1:2~1:4 | Negative | Online Inquiry |
KO28911 | CLBA1 Knockout cell line (HEK293) | Human | CLBA1 | 1:3~1:6 | Negative | Online Inquiry |
KO28912 | CLBA1 Knockout cell line (A549) | Human | CLBA1 | 1:3~1:4 | Negative | Online Inquiry |
CLBA1 Gene Knockout Cell Lines are expertly designed cellular models that specifically lack the expression of the CLBA1 gene, a crucial component implicated in various biological pathways, including immune response and inflammation. By employing advanced CRISPR-Cas9 technology, these cell lines provide researchers with a robust platform to study the intricate roles that CLBA1 plays in cellular functions, disease mechanisms, and therapeutic interventions.
Functionally, the knockout of the CLBA1 gene allows for the investigation of cellular processes that are otherwise masked by its presence, enabling scientists to elucidate the gene’s impact on signal transduction, metabolic regulation, and phenotypic behavior. Researchers can assess the changes in cellular morphology, viability, and response to external stimuli, ultimately providing insights into how CLBA1 influences pathology in conditions such as autoimmune diseases and cancers.
The scientific significance of CLBA1 Gene Knockout Cell Lines extends to various applications, including drug discovery, biomarker identification, and personalized medicine. In clinical settings, these models facilitate the exploration of potential therapeutic targets, contributing to more effective treatment strategies tailored to genetic profiles.
What sets our CLBA1 Gene Knockout Cell Lines apart from alternatives is the rigorously validated specificity and functionality, guaranteed through comprehensive genomic analysis and expression profiling. This meticulous approach ensures that researchers are equipped with reliable tools to conduct their studies with confidence.
For researchers and clinicians, utilizing CLBA1 Gene Knockout Cell Lines not only streamlines experimental design but also enhances the reproducibility of results, paving the way for groundbreaking discoveries in the understanding of gene function and disease pathology. Our company prides itself on a commitment to excellence in developing innovative biological products, backed by extensive scientific expertise and a dedication to advancing research in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.